Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Underrecognition of Sleep Disorders in Patients with Multiple Sclerosis.
Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.
[Thoughts on hot issues of neuromyelitis optica].
Pathological differences between white and grey matter multiple sclerosis lesions.
Impact of transcranial direct current stimulation on fatigue in multiple sclerosis.
The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury.
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.
Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.
Role of glial 14-3-3 gamma protein in autoimmune demyelination.
Lipopolysaccharide from Rhodobacter sphaeroides Attenuates Microglia-Mediated Inflammation and Phagocytosis and Directs Regulatory T Cell Response.
Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.
Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.
Region and dynamic specificities of adult neural stem cells and oligodendrocyte precursors in myelin regeneration in the mouse brain.
Secretory IgA Induces Tolerogenic Dendritic Cells through SIGNR1 Dampening Autoimmunity in Mice.
Selectins and their ligands as potential immunotherapeutic targets in neurological diseases.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
The MoSt Project--More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report.
[Illness, health and sunlight].
Fulminant inflammatory demyelination: long-term course and magnetic resonance imaging findings.
Pages
« first
‹ previous
…
589
590
591
592
593
594
595
596
597
…
next ›
last »